(Q40705517)

22 September 2017

title

Low-dose methotrexate treatment in elderly patients with bullous pemphigoid (English)

1 reference

22 September 2017

1 reference

Paul MA

1

1 reference

22 September 2017

Jorizzo JL

series ordinal

2

1 reference

22 September 2017

Fleischer AB Jr

series ordinal

3

1 reference

22 September 2017

White WL

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 1994

1 reference

Journal of the American Academy of Dermatology

22 September 2017

published in

1 reference

22 September 2017

volume

31

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

620-625

1 reference

Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Pemphigus and pemphigoid. A review of the advances made since 1964.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Azathioprine for pemphigus and pemphigoid--a 4 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

The Etiology and Treatment of Pemphigus and Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

The use of chlorambucil in the treatment of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Treatment of bullous pemphigoid with topical clobetasol propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate guidelines--revised

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate: mechanism of action in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate for psoriasis. A new therapeutic schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Cytotoxic agents for use in dermatology. I.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Azathioprine hypersensitivity in bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Effects of cyclosporin on bullous pemphigoid and pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Cyclosporine in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

The pharmacology of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Methotrexate: anti-inflammatory or antiproliferative?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

Role of cell-mediated immune reaction in blister formation of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970227-6

7 January 2021

10.1016/S0190-9622(94)70227-6

Identifiers

DOI

1 reference

22 September 2017

1 reference